United Pharm (033270) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.077x

Based on the latest financial reports, United Pharm (033270) has a cash flow conversion efficiency ratio of 0.077x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩35.58 Billion ≈ $24.12 Million USD) by net assets (₩459.17 Billion ≈ $311.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see United Pharm (033270) market capitalisation for the company's overall valuation and market capitalisation.

United Pharm - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how United Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

United Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of United Pharm ranked by their cash flow conversion efficiency. Explore cash flow quality index of United Pharm to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Crown Reserve Acquisition Corp. I Class A Ordinary Shares NASDAQ:CRAC	0.000x
BAPCOR LTD. F:0BS	N/A
Shangri-La Hotel Public Company Limited BK:SHANG	0.013x
Renaissance Global Limited NSE:RGL	-0.053x
Jai Corp Limited NSE:JAICORPLTD	0.004x
Galata Acquisition Corp. II Class A Ordinary Shares NASDAQ:LATA	-0.001x
AMA Group Limited F:KC7	0.047x
Shangri La Hotels Malaysia Bhd KLSE:5517	0.012x

Annual Cash Flow Conversion Efficiency for United Pharm (2011–2025)

The table below shows the annual cash flow conversion efficiency of United Pharm from 2011 to 2025. View United Pharm (033270) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩454.63 Billion ≈ $308.10 Million	₩51.14 Billion ≈ $34.65 Million	0.112x	+70.52%
2024-12-31	₩406.21 Billion ≈ $275.28 Million	₩26.79 Billion ≈ $18.16 Million	0.066x	-49.81%
2023-12-31	₩378.68 Billion ≈ $256.63 Million	₩49.77 Billion ≈ $33.73 Million	0.131x	-30.38%
2022-12-31	₩337.86 Billion ≈ $228.96 Million	₩63.78 Billion ≈ $43.22 Million	0.189x	+28.77%
2021-12-31	₩300.71 Billion ≈ $203.79 Million	₩44.09 Billion ≈ $29.88 Million	0.147x	+9.82%
2020-12-31	₩276.89 Billion ≈ $187.65 Million	₩36.96 Billion ≈ $25.05 Million	0.133x	-10.75%
2019-12-31	₩255.10 Billion ≈ $172.88 Million	₩38.15 Billion ≈ $25.86 Million	0.150x	-7.30%
2018-12-31	₩228.48 Billion ≈ $154.84 Million	₩36.86 Billion ≈ $24.98 Million	0.161x	+17.54%
2017-12-31	₩201.68 Billion ≈ $136.68 Million	₩27.68 Billion ≈ $18.76 Million	0.137x	-18.90%
2016-12-31	₩177.39 Billion ≈ $120.21 Million	₩30.02 Billion ≈ $20.34 Million	0.169x	+28.50%
2014-12-31	₩161.83 Billion ≈ $109.67 Million	₩21.31 Billion ≈ $14.44 Million	0.132x	-1.80%
2013-12-31	₩141.44 Billion ≈ $95.85 Million	₩18.97 Billion ≈ $12.85 Million	0.134x	-18.19%
2012-12-31	₩133.48 Billion ≈ $90.46 Million	₩21.88 Billion ≈ $14.83 Million	0.164x	-32.90%
2011-12-31	₩113.04 Billion ≈ $76.61 Million	₩27.62 Billion ≈ $18.72 Million	0.244x	--

About United Pharm

KO:033270 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$175.87 Million

₩259.52 Billion KRW

Market Cap Rank

#17127 Global

#673 in Korea

Share Price

₩17970.00

Change (1 day)

-1.26%

52-Week Range

₩16600.00 - ₩21400.00

All Time High

₩95918.11